The Engine for Functional Immune Cell Profiling and Receptor Discovery
We analyze, understand, and manipulate massive numbers of cells on the single cell level to develop more effective treatments for human diseases.
Powered by Our Proprietary Platform
Our proprietary ultra-high throughput single cell platform enables us to functionally profile millions of immune cells on the single cell level at the same time, pulling out rare and difficult-to-find targets that are like the needles in a haystack. This allows us to create immunotherapies that are more targeted and more effective. We are using this unique platform to first develop cell therapies for solid tumors.
Centered around people
We believe that people are the key that drives scientific and organizational successes. We are dedicated to building an environment where everyone thrives. We have a culture of collaboration, ownership, and authenticity. We are proud to have built an interdisciplinary team that embodies this culture.
.png)
.png)
Latest News
Shennon Biotechnologies Raises $13M Seed Financing to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platform
Read Article
Immunotherapy biotech unstealths with $13M; Anti-infection candidate for CF passes safety trial
Read Article
Shennon Biotechnologies Raises $13M Seed Financing to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platform
Read Article
How a onetime VC came back to science to focus on finding better targets faster against cancer
Read Article
Work With Us to Cure Cancer
